UK-based medical technology firm Smith & Nephew has signed a definitive agreement to purchase US tissue regeneration technology developer Rotation Medical for a total of approximately $210m.

Intended to support Smith & Nephew’s growth strategy, the deal will see an initial cash consideration of $125m followed by up to $85m over the coming five years, based on financial performance.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Designed for repair of shoulder rotator cuff, Rotation Medical’s system features a technology that combines biomechanics and biology for improving the natural healing response of the body.

The ability of the system to trigger new tendon-like tissue growth is expected to heal tendons by potentially preventing tear progression and minimising incidence of re-tears.

To allow reproducible procedures, the bioinductive implant comes with a disposable arthroscopic instruments set.

Smith & Nephew CEO Olivier Bohuon said: “The Rotation Medical rotator cuff system is an innovative technology serving unmet clinical needs.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
“The Rotation Medical rotator cuff system is an innovative technology serving unmet clinical needs.”

“It is highly complementary to our Sports Medicine portfolio and provides a compelling new treatment option for our customers.”

The implant can be used alone for partial tears, as well as in combination with rotator cuff tear treatment continuum or Smith & Nephew’s standard anchors and suturing technologies to repair complex tears.

According to data from clinical studies, the implant improved tendon healing by triggering growth of new tendon-like issue, leading to thick tendons and tissue defects replacement.

The rotator cuff system is set to be available through Smith & Nephew’s sports medicine and Rotation Medical’s associated sales forces.

Subject to customary conditions, the acquisition is estimated to be complete by the end of this year.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact